Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 3
1966 16
1967 20
1968 36
1969 50
1970 38
1971 38
1972 42
1973 59
1974 53
1975 81
1976 104
1977 68
1978 93
1979 114
1980 115
1981 120
1982 162
1983 157
1984 172
1985 153
1986 172
1987 186
1988 144
1989 146
1990 125
1991 118
1992 90
1993 82
1994 69
1995 71
1996 48
1997 48
1998 47
1999 42
2000 40
2001 38
2002 43
2003 47
2004 37
2005 41
2006 21
2007 35
2008 34
2009 27
2010 35
2011 33
2012 38
2013 46
2014 34
2015 34
2016 34
2017 41
2018 29
2019 11
2020 19
2021 7
Text availability
Article attribute
Article type
Publication date

Search Results

3,725 results
Results by year
Filters applied: . Clear all
Page 1
Reduction of PTSD Symptoms With Pre-Reactivation Propranolol Therapy: A Randomized Controlled Trial.
Brunet A, Saumier D, Liu A, Streiner DL, Tremblay J, Pitman RK. Brunet A, et al. Am J Psychiatry. 2018 May 1;175(5):427-433. doi: 10.1176/appi.ajp.2017.17050481. Epub 2018 Jan 12. Am J Psychiatry. 2018. PMID: 29325446 Clinical Trial.
The hypothesis predicted a significant treatment effect of trauma reactivation with propranolol compared with trauma reactivation with placebo in reducing PTSD symptoms on both the Clinician-Administered PTSD Scale (CAPS) and the patient-rated PTSD Checklist-Specific (PCL- …
The hypothesis predicted a significant treatment effect of trauma reactivation with propranolol compared with trauma reactivation wit …
Status of propranolol for treatment of infantile hemangioma and description of a randomized clinical trial.
Menezes MD, McCarter R, Greene EA, Bauman NM. Menezes MD, et al. Ann Otol Rhinol Laryngol. 2011 Oct;120(10):686-95. doi: 10.1177/000348941112001010. Ann Otol Rhinol Laryngol. 2011. PMID: 22097156 Review.
Our secondary objective was to describe a randomized, controlled, single-blinded trial comparing propranolol to prednisolone for treatment of IH. METHODS: Ovid Medline and PubMed searches were completed for the MeSH keywords "propranolol" and "hemangioma." ...Fastid …
Our secondary objective was to describe a randomized, controlled, single-blinded trial comparing propranolol to prednisolone for trea …
Propranolol and migraine. A clinical trial.
Pita E, Higueras A, Bolaños J, Pérez N, Mundo A. Pita E, et al. Arch Farmacol Toxicol. 1977 Dec;3(3):273-8. Arch Farmacol Toxicol. 1977. PMID: 350168 Clinical Trial. No abstract available.
Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial.
Knight JM, Rizzo JD, Hari P, Pasquini MC, Giles KE, D'Souza A, Logan BR, Hamadani M, Chhabra S, Dhakal B, Shah N, Sriram D, Horowitz MM, Cole SW. Knight JM, et al. Blood Adv. 2020 Feb 11;4(3):467-476. doi: 10.1182/bloodadvances.2019000765. Blood Adv. 2020. PMID: 32027744 Free PMC article. Clinical Trial.
Propranolol was administered for 1 week prior to and 4 weeks following HCT. ...Changes in these pathways make propranolol a potential candidate for adjunctive therapy in cancer-related HCT....
Propranolol was administered for 1 week prior to and 4 weeks following HCT. ...Changes in these pathways make propranolol a po
Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial.
Filippi L, Cavallaro G, Bagnoli P, Dal Monte M, Fiorini P, Berti E, Padrini L, Donzelli G, Araimo G, Cristofori G, Fumagalli M, la Marca G, Della Bona ML, Pasqualetti R, Fortunato P, Osnaghi S, Tomasini B, Vanni M, Calvani AM, Milani S, Cortinovis I, Pugi A, Agosti M, Mosca F. Filippi L, et al. Pediatr Res. 2017 Feb;81(2):307-314. doi: 10.1038/pr.2016.230. Epub 2016 Nov 4. Pediatr Res. 2017. PMID: 27814346 Clinical Trial.
BACKGROUND: Oral propranolol reduces retinopathy of prematurity (ROP) progression, although not safely. ...CONCLUSION: Propranolol 0.1% eye micro-drops are well tolerated, but not sufficiently effective. ...
BACKGROUND: Oral propranolol reduces retinopathy of prematurity (ROP) progression, although not safely. ...CONCLUSION: Propranolol
Comparative trial of propranolol and practolol in hyperthyroidism.
Nelson JK, McDevitt DG. Nelson JK, et al. Br J Clin Pharmacol. 1975 Oct;2(5):411-6. doi: 10.1111/j.1365-2125.1975.tb00549.x. Br J Clin Pharmacol. 1975. PMID: 786352 Free PMC article. Clinical Trial.
Propranolol and practolol reduced heart rate by 24 and 17% respectively compared with placebo. 5. ...Only in its effect on heart rate was practolol significantly inferior to propranolol, and it would appear to be a useful alternative to propranolol in the man
Propranolol and practolol reduced heart rate by 24 and 17% respectively compared with placebo. 5. ...Only in its effect on heart rate
A comparative trial of flunarizine and propranolol in the prevention of migraine.
Shimell CJ, Fritz VU, Levien SL. Shimell CJ, et al. S Afr Med J. 1990 Jan 20;77(2):75-7. S Afr Med J. 1990. PMID: 2404346 Clinical Trial.
The calcium-entry blocker flunarizine (Sibelium; Janssen) was compared with the beta-adrenoreceptor-blocking agent propranolol in the prophylaxis of migraine. Fifty-eight patients were entered into a double-blind 4-month treatment trial. ...Both flunarizine and proprano
The calcium-entry blocker flunarizine (Sibelium; Janssen) was compared with the beta-adrenoreceptor-blocking agent propranolol in the …
Controlled clinical trial of propranolol alone and in combination with dilazep in patients with angina pectoris.
Biswas NR, Pandhi P, Wahi PL, Sharma PL. Biswas NR, et al. Int J Clin Pharmacol Ther Toxicol. 1990 Jun;28(6):241-4. Int J Clin Pharmacol Ther Toxicol. 1990. PMID: 2198233 Clinical Trial.
The present study was performed to see if the combined treatment with propranolol and dilazep offers any advantage over monotherapy with propranolol alone in angina of effort. ...Propranolol in combination with dilazep produced more reduction in these paramet …
The present study was performed to see if the combined treatment with propranolol and dilazep offers any advantage over monotherapy w …
Effects of atenolol and propranolol on platelet aggregation in moderate essential hypertension: randomized crossover trial.
Punda A, Polić S, Rumboldt Z, Bagatin J, Marković V, Lukin A. Punda A, et al. Croat Med J. 2005 Apr;46(2):219-24. Croat Med J. 2005. PMID: 15849842 Free article. Clinical Trial.
The LDL-cholesterol concentration increased significantly in propranolol compared with both baseline and atenolol period. Serum triglycerides increased significantly with both medications. ...CONCLUSION: Propranolol inhibits platelet aggregation more than atenolol a …
The LDL-cholesterol concentration increased significantly in propranolol compared with both baseline and atenolol period. Serum trigl …
Comparative trial of atenolol and propranolol in hyperthyroidism.
McDevitt DG, Nelson JK. McDevitt DG, et al. Br J Clin Pharmacol. 1978 Sep;6(3):233-7. doi: 10.1111/j.1365-2125.1978.tb04590.x. Br J Clin Pharmacol. 1978. PMID: 356867 Free PMC article. Clinical Trial.
1 The use of atenolol, a cardioselective beta-adrenoceptor antagonist, in the management of hyperthyroidism has been studied by comparing it with propranolol. 2 In a double-blind cross-over trial, atenolol (50 mg), propranolol (40 mg) and placebo 4 times daily for 1 …
1 The use of atenolol, a cardioselective beta-adrenoceptor antagonist, in the management of hyperthyroidism has been studied by comparing it …
3,725 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page